IGM BIOSCIENCES INC (IGMS) Stock Income Statement
NASDAQ:IGMS - Nasdaq - US4495851085 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.68M | 2.68M | 2.13M | 1.07M | 0.00 | |||
| Operating Expenses | 174.23M | 196.90M | 265.59M | 229.03M | 165.32M | |||
| Research and Development | 132.10M | 155.19M | 215.52M | 179.29M | 127.03M | |||
| Selling, General, and Administrative Expenses | 42.13M | 41.71M | 50.07M | 49.74M | 38.30M | |||
| Operating Income | -171.55M | -194.22M | -263.46M | -227.96M | -165.32M | |||
| Interest Income/Expense | 10.63M | 12.79M | 17.74M | 7.04M | N/A | |||
| Other Income/Expense | N/A | 0.00 | -20.00K | -180.00K | 160.00K | |||
| Non Recurring Items | N/A | -14.36M | N/A | N/A | N/A | |||
| Income Before Taxes | -198.87M | -195.79M | -245.74M | -221.10M | -165.16M | |||
| Income Tax | N/A | 0.00 | 678.00K | N/A | N/A | |||
| Net Income | -198.87M | -195.79M | -246.42M | -221.10M | -165.16M | |||
| EBITDA | -162.34M | -185.10M | -255.18M | -221.88M | -160.84M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.27 | -3.24 | -4.71 | -5.32 | -4.93 | |||
| Non GAAP EPS | -2.92 | -3.24 | -4.81 | -5.37 | -4.93 | |||
| Statistics | ||||||||
| Profit Margin | -7417.79% | -7308.51% | -11568.83% | -20663.55% | N/A | |||
| Operating Profit Margin | -6398.81% | -7249.61% | -12369.06% | -21304.67% | N/A | |||
All data in USD